About EyRIS

When you are having your eyes checked every year, have you ever thought that
community optometrists are also considered as healthcare professionals rather than merely operating a business selling glasses or contact lenses? Their roles in primary eye care service are beyond just prescribing glasses or contact lenses. In fact, they are frontliners, also known as primary eye care practitioners, skillful in detecting eye diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration, etc. Qualified optometrists are trained and go through a stringent university optometry degree program, either in Malaysia or overseas. However, in Malaysia, their roles are not fully utilised or appreciated as they are rather isolated from the rest of healthcare practitioners. As part of a multidisciplinary healthcare team, community optometrists should work hand-in-hand with private GPs and community pharmacists to provide valuable eye care services. Overall, it would improve the eye care awareness, as well as detecting early signs of sight threatening conditions such as diabetic retinopathy and glaucoma, among others.

In order to address this health issue, Rhazes Consultancy Services Sdn Bhd (RCS), a knowledge-based telehealth service provider, through their service Rhazes TeleOpto, has collaborated with Nova MSC Bhd (Nova MSC), an appointed distributor of EyRIS Pte Ltd’s (EyRIS) products, and Association of Malaysia Optometrists (AMO) to bring EyRIS’ Artificial Intelligence (AI) Deep Learning Technology, SELENA+ to mainstream adoption in Malaysia. Under this collaboration, SELENA+ will be deployed to more than 1,000 AMO’s members across Malaysia via Rhazes TeleOpto service. This three parties’ collaboration and the deployment of SELENA+ to AMO’s member practices across the country will help to standardise and improve the range and quality of eye care services.

Here comes the product — EyRIS SELENA+

SELENA+ has been deployed as mainstream adoption in healthcare services across
26 countries. EyRIS’s SELENA+ has been approved for use by Malaysia Medical
Device Authority since 22nd June 2020. As of today, SELENA+ can detect up to three retinal diseases. They are:

● Diabetic retinopathy
● Glaucoma suspect
● Age-related macular degeneration

In addition, a new algorithm will be added to detect chronic kidney disease (CKD)
through the same fundus image used by EyRIS’ SELENA+ within the next few
months. EyRIS is expanding disease detection capabilities through its innovative AI
deep learning technology, where it can think and make decisions like human
intelligence. EyRIS has also linked a research collaboration agreement with National
Healthcare Group (NHG) earlier in the year to develop a new proprietary AI that
detects melanoma using mobile phone cameras.

SELENA+ uses non-invasive fundus imaging and generates results within 10-15
seconds with ease, speed and accuracy. With the use of SELENA+, patients will be
able to receive their results in minutes as compared to the current waiting time of
about a day!

Rhazes Consultancy Services (RCS) x EyRIS SELENA+

RCS is the first platform globally that integrates with EyRIS Singapore, to ensure delivery of outstanding quality professional eye care service in Malaysia. Their goal is to deliver teleoptometry where healthcare services can be delivered even from a remote location. This ensures everyone enjoys easy access to healthcare service regardless of their location. RCS platform links community optometrists to patients and community pharmacists and vice versa. Community optometrists on Rhazes diagnose the eye conditions based on fundus results and refer the patients either to ophthalmologists or community pharmacy on Rhazes TelePharmacy to obtain the necessary counselling on medications, lifestyle or disease.

How SELENA+ works.

Retinal image using digital fundus photograph is obtained and is submitted electronically to Rhazes webpage.

The retinal image is then sent to SELENA+ for analysis using intelligent deep learning technology for early detection of diabetic retinopathy, glaucoma, age-related macular degeneration.
Assessment report is delivered to the community optometrist within a few seconds.

Our Specialist

Daleelah Md Nor

Community Optometrist

Zulkifli Jaffar

Community Optometrist

Chan May May

Community Optometrist

Maryam Jameela

Community Optometrist

Benny Chian

Community Optometrist

Norliza Ramli

Community Optometrist

Shahrudin Haron @ Don Denai

Community Optometrist

Ong Mei Chin

Community Optometrist

Ready to Get Your First Online Consultation?

Need help?

Get in touch with us

+6 013 482 0150